Novartis (NVS), Sanofi-Aventis (SNY), Glaxo (GSK) to Receive $661M of $1B Set Side for Developing H1N1 Flu Vaccine -CNBC
Tweet Send to a Friend
According to CNBC's Mike Huckman, European pharma companies are expected to get at least $661 million of the $1 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
